Experimental Pharmacology
&
Analytical Biochemistry
This unit supplies biochemical and cell-based screenings aimed to assess the biological activity and toxicity profile of small molecules and/or biologics.
The custom cell-based assays and the high-throughput screening (HTS) platforms allow to rapidly characterize the test compound in terms of mechanism of action, cytotoxicity and other properties.
Experimental Activities
![]() |
Cell culture (maintenance and storage, tests for pathogens and toxins identifications) |
|
![]() |
Isolation of new primary cell lines |
|
![]() |
Cytotoxicity and proliferation assays |
|
![]() |
XC50 testing and confirmations |
|
![]() |
Signal transduction assays |
|
![]() |
Reporter gene assays |
|
![]() |
Cytokine release assays |
|
![]() |
FACS |
|
![]() |
Chemotaxis, migration and angiogenesis |
|
![]() |
Live Cell Imaging (Operetta High-Content Imaging System) |
|
![]() |
Evaluation of ligand-receptor affinity by SPR (Biacore T200) |
|
![]() |
Immunoassays (ELISA, Western blot, Immunofluorescence) |
|
On the basis of the experimental requirements it is possible to choose between more than 100 cellular models, including: |
||
![]() |
stabilized cell lines |
|
![]() |
primary cells from different tumour types |
|
![]() |
unique pre-clinical models of malignant mesothelioma |
|
![]() |
engineered cell lines expressing GFP or Luciferase reporter genes
|
|